Skip to content

Posts tagged ‘science’

Processing scientific data for analysis and insight

February 14th, 2011

Daedalus

Cover of Science Feb 11 2011 on Dealing with Data Processing scientific data for analysis and insight

Today on Pharma Strategy Blog, Sally Church comments on the sheer volume of data associated with modern science, a topic considered by Science magazine in their February 11, 2011 issue.

What makes this close to our heart at Icarus Consultants, is that what we do for a living as a marketing strategy company focusing on the life sciences, pharmaceutical and biotechnology industries,  is process a lot of data.  Anybody can provide you with a data dump of all the posters or presentations from a scientific meeting, but what does this data mean, what do the key opinion leaders think and what are the strategic implications that come out of it?

In the internet era, the amount of data available to us is increasing, but we are faced by more demands on our time.  That’s why people often hire us, not to do what they cannot do themselves, but what they don’t have the time to do. It takes time to process data and generate analysis and insight.

More perspective on this topic can be found on Pharma Strategy Blog.

Icarus Consultants to attend ISGC Meeting in Houston

January 4th, 2011

Daedalus

Sally Church, PhD will be attending the 6th International Society of Gastroenterological Carcinogenesis (ISGC) meeting in Houston from Thursday 6th to Saturday, 8th January, 2011. Hosted by the MD Anderson Cancer Center, the meeting has an impressive line up of key opinion leaders. Further information can be found on the Pharma Strategy Blog.

Update on circulating tumor cells in colorectal cancer

December 29th, 2010

Daedalus

Published by Sally Church on Pharma Strategy Blog

My impressions of ASH

December 22nd, 2010

Daedalus

Published by Pieter Droppert on Biotech Strategy Blog

DNMT3A Mutations in Acute Myeloid Leukemia – an update

December 21st, 2010

Daedalus

Published by Sally Church on Pharma Strategy Blog

Targeting BAP1 – a future targeted therapy for Uveal Melanoma?

December 21st, 2010

Daedalus

Published by Pieter Droppert on Biotech Strategy Blog

Nuclear Receptor expression defines a set of prognostic biomarkers for lung cancer

December 20th, 2010

Daedalus

Published by Sally Church on Pharma Strategy Blog

FGFR as a target in lung cancer

December 17th, 2010

Daedalus

Published by Sally Church on Pharma Strategy Blog

DNA-Repair Pathways: Cancer Syndromes to Novel Therapies

December 15th, 2010

Daedalus

Published by Sally Church on Pharma Strategy Blog